Login

The article explores how technology is disrupting home insurance, featuring insights from Lemonade Inc. CEO. 00:10:00

Share On Facebook Share On Twitter

John has served as LivePerson's CEO since January 2024.

Recent Videos

00:17:08
Urasar is 100% Hayasa Metals Inc. owned; our exploration license over the Urasar mineral district
00:10:00
Dryden Gold Secures $20M+ War Chest, Delivers High-Grade Discoveries and Expands Drill Targets Across Gold Rock District|Trey Wasser,CEO & Director,Dryden Gold 1
00:10:00
Mitchell Services Targets $50–60M EBITDA as Rig Utilization Drives Earnings Upside| Andrew Elf,CEO,Mitchell Services Limited
00:10:00
Lomiko Metals Reports Strong Pre-Feasibility Results with $800M NPV, Advancing High-Growth Graphite Projects|Gordana Slepcev,CEO,Lomiko Metals Inc.4
00:10:00
Generative AI Meets Wet Lab: Absci Accelerates Biologic Development with Hybrid Business Model|Sean McClain,CEO,Absci
00:10:00
Obliva Aims to Transform Lives of Children with Rare Mitochondrial Disorders|Ellen K. Donnelly ,CEO,Abliva AB7
00:10:00
Abionic Repositions Bio-HDL Therapy CCR001 for Rare Kidney and Eye Disorders with Promising Early Results|Cyrille Tupin,CEO,ABIONYX Pharma
00:10:00
Abingdon Health Reports 45% H1 Revenue Growth Amid Strategic Expansion and Large Contract Wins|Dr Chris Hand,Chairman,Abingdon Health
00:10:00
EB-101 Gene Therapy Shows Promising Results in Treating Recessive Dystrophic EB|Vishwas Seshadri,CEO,Abeona Therapeutics
00:10:00
Revolutionizing Trauma Care: How AAP’s Silver Technology is Fighting Deadly Implant Infections|Rubino Di Girolamo,CEO,aap Implantate AG
00:10:00
Revolutionizing Cancer Treatment: Tumor-Agnostic mTOR Targeting Shows Breakthrough Success in Rare and Genetic-Driven Tumors| Neil Desai, Founder, Executive Chairman ,Aadi Bioscience
00:10:00
Millions Affected, No Approved Cure: 89bio Advances New Therapy for NASH|Rohan Palekar,CEO,89bio Inc2
00:10:00
Malaria Prevention Drug Arakoda Positioned to Drive Future Growth for 60 Degrees Pharmaceuticals|Geoffrey Dow,President,60 Degrees Pharmaceuticals
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4DMedical Revolutionizes Lung Imaging with CTVQ: Turning a Simple CT Scan into Functional Lung Diagnostics|Dr Andreas Fouras,CEO,4Dmedical Ltd
00:10:00
4basebio CEO Heikki Lanckriet Unveils Vision for Next-Generation Synthetic DNA and Gene Therapy Components|Heikki Lanckriet,CEO,4basebio

Suggestions

00:10:00
Ariel Investments' Founder John Rogers on Achieving Market-Beating Returns
00:10:00
Insights from UniCredit's CEO Andrea Ortel on Market Challenges and Strategic Plans | Andrea Orcel, CEO , UniCredit.
00:10:00
Sitowise Group: A Leader in Construction, Infrastructure, and Sustainability with CEO Heikki Haasmaa | Heikki Haasma, CEO, Sitowise Group Oyj.
00:10:00
FBN, a unit of FOX News Media with bureaus in Chicago, discusses Rumble's view that Twitter caused 'the worst, most egregious' implications.
00:10:00
BBVA Reports Strong Financial Performance and Strategic Expansion | Onur Genç , CEO , BBVA .
00:10:00
The Hidden Costs of Renewable Energy Credits: A Warning for Corporates | William Gore-Randall - Research Analyst at Lazard Asset Management
00:10:00
Exploring Investment Philosophy and Products with José María Concejo of Horos Asset Management
00:10:00
Tim Brown on Allbirds' Journey: From Pro Soccer to Sustainable Footwear Innovation | Tim Brown, Co-Founder, Allbirds Inc.
00:10:00
Chris Flowers on Financial Crises: Reflections and Future Risks | Chris Flowers, CEO, J.C. Flowers & Co.
00:10:00
E-Book Subscription Pioneer Legimi Eyes Growth in Germany and Beyond, Says CEO Małaczyński |Mikołaj Małaczyński ,CEO , Legimi S.A.
00:10:00
Strategies for Attracting Investors to Your Startup: Insights from Patrick Walujo | Patrick Walujo, Co-Founder, Northstar Group.
00:10:00
VC Firm with a permanent, evergreen capital base investing in early-stage healthcare companies with line of sight|Andrew M. Paul,Founder and CEO,Sopris Capital

© 2026 Nehu